SCHEMBL12246718

SCHEMBL12246718

[C-]#[N+]c1cccc(-c2ccc3c(c2)C(=O)CC2(CCCc4ccccc4C2)O3)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.41
ATM Q13315 3/20 0.41
HTT P42858 1/20 0.41
BACE1 P56817 3/20 0.38
EPHX2 P34913 4/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ALDH1A1 P00352 3/20 0.35
HPGD P15428 3/20 0.35
HSD11B1 P28845 1/20 0.35
GAA P10253 2/20 0.34
LMNA P02545 1/20 0.34
EPHX1 P07099 2/20 0.34
SCN5A Q14524 1/20 0.34
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
HDAC3 O15379 2/20 0.33
HDAC4 P56524 2/20 0.33
HDAC1 Q13547 2/20 0.33
HDAC7 Q8WUI4 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12246645 0.95 BACE1 (0.41) KDM4EATMHTTBACE1EPHX2
SCHEMBL12246676 0.91 KDM4E (0.43) KDM4EATMHTTBACE1EPHX2
SCHEMBL12246656 0.91 KDM4E (0.39) KDM4EATMHTTBACE1EPHX2
SCHEMBL1820865 0.85 KDM4E (0.44) KDM4EATMHTTEPHX2L3MBTL1
SCHEMBL12246720 0.83 BACE1 (0.35) BACE1SLC6A2SLC6A4SLC6A3
SCHEMBL7959142 0.82 BACE1 (0.45) KDM4EATMHTTBACE1
SCHEMBL12247498 0.81 HDAC3 (0.51) KDM4EATMHTTBACE1EPHX2
SCHEMBL12247508 0.79 HDAC3 (0.40) KDM4EATMHTTEPHX2ALDH1A1
SCHEMBL12246644 0.78 BACE1 (0.38) BACE1SLC6A2SLC6A4SLC6A3
SCHEMBL1822527 0.77 KDM4E (0.49) KDM4EATMHTTEPHX2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8921359-B2 Inhibitors of beta-secretase VITAE PHARMACEUTICALS, INC. (US) 2014-12-30 US disclosed
US-8450308-B2 Inhibitors of beta-secretase VITAE PHARMACEUTICALS, INC. (US) 2013-05-28 US disclosed
US-20110218192-A1 Inhibitors Of Beta-Secretase VITAE PHARMACEUTICALS, INC. (US) 2011-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110218192-A1 Inhibitors Of Beta-Secretase BACE1, BACE2, APP KDM4E 3004/4885ATM 4610/4885HTT 808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.